Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05890859
Other study ID # LBM in HNSCC during treatment
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 5, 2015
Est. completion date May 15, 2023

Study information

Verified date May 2023
Source Department of Public Health, Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to investigate the changes in body composition in head and neck cancer patients during treatment. The main questions it aims to answer are: What is the rate of lean body mass loss and how is it associated with changes in muscle strength and functional performance? Is the lean body mass loss impacted by adding chemotherapy to the radiation treatment? Participants will be asked to undergo five body composition scans during treatment and undergo tests for muscle strength and functional performance before and after treatment.


Description:

The primary aim of the present study is to investigate the rate of decline in body composition (LBM, body weight and fat mass) as well as changes in maximal muscle strength and functional performance during radiation treatment in HNSCC patients and to investigate the association between the loss of LBM and impairments in maximal muscle strength and functional performance. Secondly, the study investigates whether adding cisplatin during chemoradiation induces exacerbated LBM loss compared to radiation alone. 50 patients are expected to be included in the study. Inclusion criteria are: (1) histologically proven squamous cell carcinoma of the larynx, pharynx, or oral cavity, (2) prescribed to radical or post-operative radiotherapy of at least 60 Gy with or without concomitant chemotherapy. Exclusion criteria were palliative radiation or participation in competing research protocols. Five times during treatment (biweekly), patients will be asked to undergo a Dual Energy X-ray Absorptiometry scan to evaluate changes in lean body mass and fat mass. Before and after treatment patients are asked to perform three test for maximal muscle strength (one repetition maximum knee extension, chest press and leg press) as well as three functional performance test (30 s arm curl, 30 s chair rise and stair climb).


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date May 15, 2023
Est. primary completion date July 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Histologically proven squamous cell carcinoma of the larynx, pharynx, or oral cavity - Prescribed to radical or post-operative radiotherapy of at least 60 Gy with or without concomitant chemotherapy Exclusion Criteria: - Palliative radiation or participation in competing research protocols

Study Design


Intervention

Diagnostic Test:
DXA scan
The patients will undergo 5 DXA scans fro pre- to post treatment
Behavioral:
Physical testing
The patients will undergo tests for maximal muscle strength and functional performance before and after treatment

Locations

Country Name City State
Denmark Odense University Hospital Odense C Southern Denmark Region

Sponsors (1)

Lead Sponsor Collaborator
Department of Public Health, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Maximal muscle strength One repetition maximum in knee extension (unilateral), leg press (unilateral) and chest press (bilateral) Before and after treatment (i.e. 2-3 days before treatment start and two weeks after treatment end)
Other Stair climb performance The fastest walking/running time in a stair climb test is recorded (two flights of stairs) Before and after treatment (i.e. 2-3 days before treatment start and two weeks after treatment end)
Other Arm curl performance The maximum number of repetitions in 30 s arm curl test are recorded Before and after treatment (i.e. 2-3 days before treatment start and two weeks after treatment end)
Other Chair rise performance The maximum number of repetitions in 30 s chair rise test are recorded Before and after treatment (i.e. 2-3 days before treatment start and two weeks after treatment end)
Primary Lean body mass Lean body mass in kg determined by DXA scans Bi-weekly from treatment start to two weeks post treatment (5 scans in total)
Secondary Fat mass FAt mass in kg measured by DXA scans Bi-weekly from treatment start to two weeks post treatment (5 scans in total)
See also
  Status Clinical Trial Phase
Recruiting NCT06061315 - Effect of Collagen Peptides, in Combination With Resistance Training, on Body Composition and Muscle Strength in Untrained Men N/A
Completed NCT04655547 - Impact on Energy Intake by Implementing Recommended Food Texture Through Dietary Guidance N/A
Completed NCT04074278 - Novel Equations for Estimating Lean Body Mass in Patients With Chronic Kidney Disease
Active, not recruiting NCT05834894 - Does Muscle Mass at Intensive Care Unit Admission Determine Mortality: The Memo Study
Completed NCT02146612 - Amino Acid Usage Patterns in Daily Practice N/A
Completed NCT04585841 - The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy Phase 1